Source link : https://www.newshealth.biz/health-news/europe-awaits-decision-on-new-duchenne-drug/
The US Food and Drug Administration (FDA) has recently approved Duvyzat (givinostat), the first nonsteroidal therapy for children aged 6 years and older who have all hereditary variants of Duchenne muscular dystrophy (DMD). The application for the drug ‘s marketing authorization in Europe is also now underway, where DMD affects approximately 0.5 in 10,000 individuals, […]
Author : News Health
Publish date : 2024-06-21 11:36:16
Copyright for syndicated content belongs to the linked Source.
Categories